DOES CIGARETTE SMOKING, WHEN COMBINED WITH NAFLD, ALTER THE EXPRESSION OF CYP2D AND CYP2C?

被引：0
|
作者：
Pilote, S. [1 ]
Thibauilt, C. [1 ]
Jubinville, E. [1 ]
Routhier, J. [1 ]
Morissette, M. C. [1 ]
Drolet, B. [1 ]
Simard, C. [1 ]
机构：
[1] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-122
引用
收藏
页码：S87 / S88
页数：2
相关论文
共 50 条
  • [21] Cloning of mouse CYP2C subfamily
    Luo, G
    Blaisdell, J
    Hodgson, E
    Goldstein, JA
    FASEB JOURNAL, 1997, 11 (09): : A824 - A824
  • [22] CYP2C and IL-6 expression in breast cancer
    Knüpfer, H
    Schmidt, R
    Stanitz, D
    Brauckhoff, M
    Schönfelder, M
    Preiss, R
    BREAST, 2004, 13 (01): : 28 - 34
  • [23] Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone
    Byeon, Ji-Young
    Cho, Chang-Keun
    Kang, Pureum
    Kim, Se-Hyung
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (08) : 713 - 721
  • [24] Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone
    Ji-Young Byeon
    Chang‑Keun Cho
    Pureum Kang
    Se-Hyung Kim
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Archives of Pharmacal Research, 2023, 46 (8) : 713 - 721
  • [25] Fenofibrate upregulates SHP expression but does not alter CYP2D6 expression
    Kent, Rebecca
    Jeong, Hyunyoung
    FASEB JOURNAL, 2016, 30
  • [26] Expression and distribution of CYP2C enzymes in rat basal ganglia
    Riedl, AG
    Watts, PM
    Douek, DC
    Edwards, RJ
    Boobis, AR
    Rose, S
    Jenner, P
    SYNAPSE, 2000, 38 (04) : 392 - 402
  • [27] CYP2C44, a new murine CYP2C that metabolizes arachidonic acid
    DeLozier, TC
    Tsao, CC
    Coulter, SJ
    Zeldin, DC
    Goldstein, JA
    DRUG METABOLISM REVIEWS, 2003, 35 : 104 - 104
  • [28] Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily
    Lewis, DFV
    Dickins, M
    Weaver, RJ
    Eddershaw, PJ
    Goldfarb, PS
    Tarbit, MH
    XENOBIOTICA, 1998, 28 (03) : 235 - 268
  • [29] IS CIGARETTE SMOKING EXACERBATING THE EFFECT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) ON CYP3A-AND CYP2C-MEDIATED DRUG METABOLISM?
    Virgili, Jessica
    Pilote, Sylvie
    Thibault, Camille
    Jubinville, Eric
    Routhier, Joanie
    Drolet, Benoit
    Morissette, Mathieu C.
    Simard, Chantale
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S37 - S38
  • [30] Epigenetic regulation of developmental expression of Cyp2d genes in mouse liver
    Li, Ye
    Zhong, Xiao-bo
    ACTA PHARMACEUTICA SINICA B, 2012, 2 (02) : 146 - 158
12345